Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Infund Holding Co., Ltd. (002141.SZ)
Dongguan, GD, CN
Infund Holding Co., Ltd. engages in the production and sales of copper clad laminates, feed, and veterinary vaccines and related technical services in China. The company offers animal nutrition; copper-clad, a plate-like material made of reinforcing materials, such as glass fiber cloth, paper base used in electrical appliances, home appliances, electronic information, involving industrial control, communication equipment, automotive electronics, security electronics, medical equipment, consumer electronics, computers and servers, transportation, aerospace and other fields. It provides vaccines for pigs, including blue ear, pseudorabies, porcine viral diarrhea and mycoplasma pneumonia diseases. In addition, it offers equity investment, asset management, external investment; and feed, biological vaccines. Infund Holding Co., Ltd. was founded in 1985 and is headquartered in Dongguan, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.36% | -0.55% | -2.93% | -7.85% | -7.61% | -2.41% | +53.59% | -3.96% | +28.62% | -49.42% | +12.57% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Other Precious Metals: +13.2%+162.2% ★ Q1'26: -31.3% (vs Q1'25)
-
EPS growth Other Precious Metals: +50.2%+115.3% ★ Q1'26: -29.0% (vs Q1'25)
-
FCF margin FCF growth · Other Precious Metals: +23.8%+2.0% Q1'26: +5.2% (vs Q1'25)
-
EBIT margin Other Precious Metals: +5.1%-2.7% Q1'26: +6.5% (vs Q1'25)
-
ROIC Other Precious Metals: +2.2%-3.5% Q1'26: +7.8% (vs Q1'25)
-
Share dilution Other Precious Metals: -3.0%-5.1% ★ Q1'26: -1.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Other Precious Metals: 0.37×22.85× Q1'26: 0.68× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2018 actual |
|---|---|
| Revenue |
1.00B
est: 1.09B (-8.2%)
|
| EBITDA |
51.45M
est: -338.56M (+115.2%)
|
| EBIT |
25.69M
est: -379.06M (+106.8%)
|
| Net Income |
7.04M
|
| SGA |
115.87M
est: 148.91M (-22.2%)
|
| EPS |
0.01
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-04-30 | C | 2/5 | 1/5 | 2/5 | 3/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-29 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-28 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-27 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Chen Ding | GM & Director | — | male |
| Danni Liang | Secretary & Deputy GM | — | female |
| Wen Bin Xie | Chief Financial Officer, Accounting Supervisor & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 002141.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
